A detailed history of Crescent Sterling, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Crescent Sterling, Ltd. holds 8,871 shares of AMGN stock, worth $2.81 Million. This represents 2.72% of its overall portfolio holdings.

Number of Shares
8,871
Previous 8,954 0.93%
Holding current value
$2.81 Million
Previous $2.8 Billion 2.17%
% of portfolio
2.72%
Previous 2.68%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $25,678 - $28,002
-83 Reduced 0.93%
8,871 $2.86 Billion
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $95,641 - $116,228
-364 Reduced 3.91%
8,954 $2.8 Billion
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $32,533 - $39,271
121 Added 1.32%
9,318 $2.65 Billion
Q4 2023

Jan 10, 2024

SELL
$255.7 - $288.46 $64,947 - $73,268
-254 Reduced 2.69%
9,197 $2.65 Billion
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $40,887 - $50,763
187 Added 2.02%
9,451 $2.54 Billion
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $51,853 - $61,315
242 Added 2.68%
9,264 $2.06 Billion
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $63,672 - $77,606
282 Added 3.23%
9,022 $2.18 Billion
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $2 Million - $2.54 Million
8,740 New
8,740 $2.3 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Crescent Sterling, Ltd. Portfolio

Follow Crescent Sterling, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Sterling, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Crescent Sterling, Ltd. with notifications on news.